Logo image of 1IRBT.MI

IROBOT CORP (1IRBT.MI) Stock Fundamental Analysis

Europe - BIT:1IRBT - US4627261005 - Common Stock

4.175 EUR
+0.36 (+9.58%)
Last: 10/20/2025, 7:00:00 PM
Fundamental Rating

1

Taking everything into account, 1IRBT scores 1 out of 10 in our fundamental rating. 1IRBT was compared to 34 industry peers in the Household Durables industry. Both the profitability and financial health of 1IRBT have multiple concerns. 1IRBT is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

1IRBT had negative earnings in the past year.
1IRBT had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: 1IRBT reported negative net income in multiple years.
1IRBT had negative operating cash flow in 4 of the past 5 years.
1IRBT.MI Yearly Net Income VS EBIT VS OCF VS FCF1IRBT.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M -300M

1.2 Ratios

1IRBT has a worse Return On Assets (-40.30%) than 94.12% of its industry peers.
Industry RankSector Rank
ROA -40.3%
ROE N/A
ROIC N/A
ROA(3y)-34.67%
ROA(5y)-17.81%
ROE(3y)-150.96%
ROE(5y)-86.07%
ROIC(3y)N/A
ROIC(5y)N/A
1IRBT.MI Yearly ROA, ROE, ROIC1IRBT.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

1IRBT has a worse Gross Margin (24.26%) than 70.59% of its industry peers.
1IRBT's Gross Margin has declined in the last couple of years.
1IRBT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 24.26%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.94%
GM growth 5Y-13.55%
1IRBT.MI Yearly Profit, Operating, Gross Margins1IRBT.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

0

2. Health

2.1 Basic Checks

1IRBT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, 1IRBT has more shares outstanding
The number of shares outstanding for 1IRBT has been increased compared to 5 years ago.
Compared to 1 year ago, 1IRBT has a worse debt to assets ratio.
1IRBT.MI Yearly Shares Outstanding1IRBT.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
1IRBT.MI Yearly Total Debt VS Total Assets1IRBT.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of -0.95, we must say that 1IRBT is in the distress zone and has some risk of bankruptcy.
1IRBT's Altman-Z score of -0.95 is on the low side compared to the rest of the industry. 1IRBT is outperformed by 94.12% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.95
ROIC/WACCN/A
WACC10.93%
1IRBT.MI Yearly LT Debt VS Equity VS FCF1IRBT.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

1IRBT has a Current Ratio of 0.54. This is a bad value and indicates that 1IRBT is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.54, 1IRBT is doing worse than 94.12% of the companies in the same industry.
1IRBT has a Quick Ratio of 0.54. This is a bad value and indicates that 1IRBT is not financially healthy enough and could expect problems in meeting its short term obligations.
1IRBT's Quick ratio of 0.34 is on the low side compared to the rest of the industry. 1IRBT is outperformed by 91.18% of its industry peers.
Industry RankSector Rank
Current Ratio 0.54
Quick Ratio 0.34
1IRBT.MI Yearly Current Assets VS Current Liabilites1IRBT.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

4

3. Growth

3.1 Past

1IRBT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 47.72%, which is quite impressive.
Looking at the last year, 1IRBT shows a very negative growth in Revenue. The Revenue has decreased by -26.60% in the last year.
Measured over the past years, 1IRBT shows a very negative growth in Revenue. The Revenue has been decreasing by -10.90% on average per year.
EPS 1Y (TTM)47.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.22%
Revenue 1Y (TTM)-26.6%
Revenue growth 3Y-24.19%
Revenue growth 5Y-10.9%
Sales Q2Q%-23.32%

3.2 Future

The Earnings Per Share is expected to grow by 33.99% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 9.89% on average over the next years. This is quite good.
EPS Next Y35.33%
EPS Next 2Y33.99%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-28.71%
Revenue Next 2Y9.89%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
1IRBT.MI Yearly Revenue VS Estimates1IRBT.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
1IRBT.MI Yearly EPS VS Estimates1IRBT.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 4 -4 -6 -8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

1IRBT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for 1IRBT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
1IRBT.MI Price Earnings VS Forward Price Earnings1IRBT.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
1IRBT.MI Per share data1IRBT.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

A more expensive valuation may be justified as 1IRBT's earnings are expected to grow with 33.99% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.99%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

1IRBT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IROBOT CORP

BIT:1IRBT (10/20/2025, 7:00:00 PM)

4.175

+0.36 (+9.58%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-03 2025-11-03
Inst Owners54.26%
Inst Owner ChangeN/A
Ins Owners3.43%
Ins Owner ChangeN/A
Market Cap130.97M
Revenue(TTM)594.60M
Net Income(TTM)-193560000
Analysts45.71
Price Target9.85 (135.93%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)12.92%
Min EPS beat(2)-50.53%
Max EPS beat(2)76.37%
EPS beat(4)2
Avg EPS beat(4)40.2%
Min EPS beat(4)-50.53%
Max EPS beat(4)152.06%
EPS beat(8)4
Avg EPS beat(8)16.02%
EPS beat(12)5
Avg EPS beat(12)-79.34%
EPS beat(16)8
Avg EPS beat(16)-43.84%
Revenue beat(2)1
Avg Revenue beat(2)-10.15%
Min Revenue beat(2)-20.34%
Max Revenue beat(2)0.05%
Revenue beat(4)1
Avg Revenue beat(4)-10.05%
Min Revenue beat(4)-20.34%
Max Revenue beat(4)0.05%
Revenue beat(8)2
Avg Revenue beat(8)-8.73%
Revenue beat(12)3
Avg Revenue beat(12)-12.03%
Revenue beat(16)4
Avg Revenue beat(16)-10.45%
PT rev (1m)0%
PT rev (3m)-7.21%
EPS NQ rev (1m)28.57%
EPS NQ rev (3m)-1100%
EPS NY rev (1m)-30.84%
EPS NY rev (3m)-186.1%
Revenue NQ rev (1m)-9.33%
Revenue NQ rev (3m)-29.21%
Revenue NY rev (1m)-4.79%
Revenue NY rev (3m)-28.66%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.26
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.66
EYN/A
EPS(NY)-0.97
Fwd EYN/A
FCF(TTM)-1.91
FCFYN/A
OCF(TTM)-1.91
OCFYN/A
SpS16.33
BVpS-0.21
TBVpS-5.31
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -40.3%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 24.26%
FCFM N/A
ROA(3y)-34.67%
ROA(5y)-17.81%
ROE(3y)-150.96%
ROE(5y)-86.07%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.94%
GM growth 5Y-13.55%
F-Score3
Asset Turnover1.24
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.54
Quick Ratio 0.34
Altman-Z -0.95
F-Score3
WACC10.93%
ROIC/WACCN/A
Cap/Depr(3y)11.65%
Cap/Depr(5y)43.11%
Cap/Sales(3y)0.46%
Cap/Sales(5y)1.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)47.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.22%
EPS Next Y35.33%
EPS Next 2Y33.99%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-26.6%
Revenue growth 3Y-24.19%
Revenue growth 5Y-10.9%
Sales Q2Q%-23.32%
Revenue Next Year-28.71%
Revenue Next 2Y9.89%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y16.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year117.97%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-344.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-281.27%
OCF growth 3YN/A
OCF growth 5YN/A